Learn how the Center for Behavioral Health Statistics and Quality works across SAMHSA and the U.S. Department of Health & Human Services to plan, implement, and monitor program evaluations. SAMHSA.gov, Material Abuse and Mental Health Auxiliary Administration. Division of Pharmacologic Therapies, SAMHSA/CSAT OTP Extranet endstream endobj 843 0 obj <. and processing of your request, SAMHSA recommends you obtain all required supporting To sign up for updates or to access your subscriber preferences, please enter your contact information. 5600 Fishers Lane, Rockville, MD 20857 and a description of the accreditation bodys appeals process to allow OTPs to contest SAMHSA's mission is to lead public health and service delivery efforts that promote mental health, prevent substance misuse, and provide treatments and supports to foster recovery while ensuring equitable access and better outcomes. This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network. DPT@SAMHSA.HHS.Gov. Division of Pharmacologic Therapies. Have a question about government service? hb```nB ce`aX$0m J6U?\?D`ynE%)6,&8 g3:uLdGJ>l{(U&%*Q %)U+g9:7t. NZHJ`+f0)A qT8:-f"G Gq#by7CY0312ng$XlXln,e7sNoCjui3M+c . hours to be worked by physicians, nurses, and counselors. Last Updated: 01/25/2023 Medications to Treat OPIOID ADDICTION Methadone Naltrexone Buprenorphine Buprenorphine Waiver Contacts Program closure-holiday take-homes refers to take-home medication when a program is closed on Sundays, or state and federal holidays. This system is provided for Government-authorized use only. adverse accreditation decisions. Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties. new search. To sign up for updates or to access your subscriber preferences, please enter your contact information. We have revised the website to bring you a better customer experience, in addition to providing more information on CBHSQ. Time in treatment take-homes refers to a single dose of take-home medications when the patient has met the minimum stabilized time-in-treatment schedule set forth under 42 CFR Section 8.12(i)(3). Best viewed in IE 8.0 or above in screen resolution 1024 by 768 pixels. 842 0 obj <> endobj After the request is verified, the applicant will receive an email with a username and password for use of the website. This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network. SAMHSA has developed a Buprenorphine Quick Start Guide (PDF | 1.4 KB)andpocket guide (PDF | 200 KB) for all practitioners seeking to prescribe buprenorphine. official will need to login to the SAMHSA OTP Extranet Website in order to By using this system, you understand and consent to the following: SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities. H2v- =f@l&F`4!3? 5l wish to PMP AWAE New Mexico PMP nm.pmp@rld.nm.gov. Warning: Only authorized users are allowed to access the application. U.S. Department of Health & Human Services. Visit the SAMHSA YouTube channel, Visit SAMHSA on LinkedIn The Program Sponsor's name and contact information, including telephone number and e-mail address, are required on the form. Contact USA.gov. Physicians may register for an Extranet account The National Survey on Drug Use and Health (NSDUH), formerly the National Household Survey on Drug Abuse, is an annual survey conducted since 1990. information and documents for your SMA-163 submission. Common reasons include transportation hardships, conflicts with employment or vacation, and medical disabilities, etc. Center at OTP-Help@jbsinternational.com, Substance Abuse and Mental Health Services Administration. We will also soon be releasing a refreshed Data Tools (formerlyPDAS/RDAS)site to help with analyzing CBHSQ data. View how approved and updated evaluation policies and procedures (P&P) guide SAMHSAs evaluation work. An affirmative statement that the treatment program will use containers having safety closures for all take-home medication dispensed to outpatients. Visit SAMHSA on Twitter. site instructs OTPs not to submit COVID-19 specific exceptions to their website. This is an excellent result, as only 5% of websites can load faster. fulfilling Internal Revenue Service requirements as a nonprofit organization) if The following supporting documentation is required to be provided with an SMA-162 A description of the organizational structure of the program. SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities. It also measures substance use disorders and mental health care. Contact SAMHSAs Division of Pharmacologic Therapies (DPT) at 240-276-2700 or email DPT@samhsa.hhs.gov. Form SMA-163 for renewal of accreditation must Visit SAMHSA on Instagram What Information Is Required on the SMA-163 Form? Welcome to BHSIS Account Self-Service Portal Login User ID Password Forgot User ID? SAMHSA OTP extranet website (see below link). OTP Extranet Access. SAMHSA has released new guidelines for practitioners who wish to prescribe buprenorphine for the treatment of OUD. complete the submission process. 1-877-SAMHSA-7 (1-877-726-4727), Submit an Opioid Treatment Exception Request, SAMHSA.gov, Substance Abuse and Mental Health Services Administration, Buprenorphine Physician & Treatment Program Locator, Early Serious Mental Illness Treatment Locator, View All Helplines and Treatment Locators, Implementing Behavioral Health Crisis Care, Mental Health and Substance Use Disorders, Substance Abuse and Mental Health Prevention, Technology Transfer Centers (TTC) Program, State Targeted Response Technical Assistance (STR-TA), Clinical Support System for Serious Mental Illness (CSS-SMI), Suicide Prevention Resource Center (SPRC), African American Behavioral Health Center of Excellence, Asian American, Native Hawaiian, and Pacific Islander Behavioral Health Center of Excellence (AANHPI-CoE), Center of Excellence for Building Capacity in Nursing Facilities to Care for Residents with Behavioral Health Conditions, Center of Excellence for Protected Health Information (CoE-PHI), Center of Excellence on Social Media and Mental Wellbeing (SMMW-CoE), Rural Opioid Technical Assistance Regional Centers (ROTA-R), Engage, Educate, Empower for Equity: E4 Center of Excellence for Behavioral Health Disparities in Aging, LGBTQ+ Behavioral Health Equity Center of Excellence, National Center of Excellence for Eating Disorders (NCEED), National Center of Excellence for Tobacco-Free Recovery, National Center on Substance Abuse and Child Welfare (NCSACW), National Family Support Technical Assistance Center (NFSTAC), National Institutes of Health (NIH) Training Resources, National Training and Technical Assistance Center for Child, Youth, and Family Mental Health, Providers Clinical Support SystemUniversities, Tribal Training and Technical Assistance Center, National Center of Excellence for Integrated Health Solutions, Mental Illness and Substance Use in Young Adults, Resources for Families Coping with Mental and Substance Use Disorders, Screening and Treatment of Co-Occurring Disorders, FY 2020 Funding Announcements and Grant Awards, FY 2021 Funding Announcements and Grant Awards, FY 2019 Funding Announcements and Grant Awards, FY 2018 Funding Announcements and Grant Awards, FY 2017 Funding Announcements and Grant Awards, FY 2016 Funding Announcements and Grant Awards, FY 2015 Funding Announcements and Grant Awards, FY 2014 Funding Announcements and Grant Awards, FY 2013 Funding Announcements and Grant Awards, FY 2012 Funding Announcements and Grant Awards, FY 2011 Funding Announcements and Grant Awards, FY 2010 Funding Announcements and Grant Awards, FY 2009 Funding Announcements and Grant Awards, FY 2008 Funding Announcements and Grant Awards, FY 2007 Funding Announcements and Grant Awards, FY 2006 Funding Announcements and Grant Awards, FY 2005 Funding Announcements and Grant Awards, National Survey of Substance Abuse Treatment Services, Evidence-Based Practices (EBP) Resource Center, Interagency Task Force on Trauma-Informed Care, Protection & Advocacy for Individuals with Mental Illness (PAIMI) Program, Asian American, Native Hawaiian, and Pacific Islander, Disaster Preparedness, Response, and Recovery, Qualitative and Quantitative Assessment Methods, Early Serious Mental Illness (ESMI) Treatment Locator, Faith-Based and Community Initiatives (FBCI), Historically Black Colleges and Universities Center of Excellence in Behavioral Health, Mental and Substance Use Disorders and Homelessness Resources, Medications, Counseling, and Related Conditions, Pharmacist Verification of Buprenorphine Providers, Become an Accredited and Certified Opioid Treatment Program (OTP), Buprenorphine Dispensing by Opioid Treatment Programs (OTPs), Become a SAMHSA-Approved Opioid Treatment Program (OTP) Accrediting Body, Notify SAMHSA of Opioid Treatment Program (OTP) Changes, About SAMHSAs Division of Pharmacologic Therapies (DPT), Mental Health Awareness and Training Grant (MHAT), National Child Traumatic Stress Initiative (NCTSI), Recognizing and Treating Child Traumatic Stress, Entendamos el estrs traumtico infantil y cmo ayudar, National Children's Mental Health Awareness Day, National Consumer and Consumer Supported Technical Assistance Center (NCTAC), National Network to Eliminate Disparities in Behavioral Health (NNED), Networking, Certifying, and Training Suicide Prevention Hotlines and the Disaster Distress Helpline, Screening, Brief Intervention, and Referral to Treatment, Substance Use Disorder Treatment Providers, Person- and Family-centered Care and Peer Support, Care Provision, Coordination, and Patient Privacy, Developing a Continuity of Operations Plan, Comparta los resultados y retroalimentacin, The Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD), The Power of Perceptions and Understanding, What You Can Do To Prevent Your Child From Drinking, Why You Should Talk With Your Child About Alcohol and Other Drugs, Why Small Conversations Make a Big Impression, How To Tell If Your Child Is Drinking Alcohol, COVID-19 Information for SAMHSA Discretionary Grant Recipients, Training and Technical Assistance Related to COVID-19, Listening Session Comments on Substance Abuse Treatment Confidentiality Regulations, Advisory Committee for Womens Services (ACWS), Tribal Technical Advisory Committee (TTAC), Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC), Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC), Interdepartmental Substance Use Disorders Coordinating Committee Biographical Information, Interdepartmental Substance Use Disorders Coordinating Committee Roster, Certification of Opioid Treatment Programs, 42 Code of Federal Regulations (CFR) 8, Federal Guidelines for Opioid Treatment Programs 2015, A temporary increase in the number of take-home doses permitted for unsupervised use, An exception to the detoxification standards in the regulation, U.S. Department of Health & Human Services. Treatment Program (OTP). Note that current registration categories do not include nursing, although nurses may register under another category such as counselor. substance Abuse and Mental Health Services Administration (SAMHSA) an agency of the United States Department of Health and Human Services, created in 1992 to oversee the quality . The submission process will not be complete until the responsible official electronically signs the form. Ready to go? If a patient meets the time-in-treatment criteria for take-home doses, the patient is not automatically eligible to receive those take-home medications. Provides planning and management of program evaluation across SAMHSA. Visit the SAMHSA Store to find information about evidence-based practices. For more information, or if you have any questions, please contact the BHSIS Helpdesk at 1-833-888-1553 (Mon-Fri 8am to 6pm EST) or BHSISHelpdesk@hendall.com. However, failure to submit and obtain approval from SAMHSA and (where applicable) the state opioid treatment authority before providing care that deviates from the federal opioid treatment standards constitutes a serious regulatory violation. SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities. All OTPs have an account on the site. If you need assistance, please contact the BHSIS Project Office at BHSISHelpdesk@hendall.com or 1-833-888-1553.
Macaroni Grill Closing,
1998 American Eagle Motorhome Specs,
Tl23 Medtronic,
Pulaski County Most Wanted 2020,
Moe's Adobo Chicken,
Articles S